• Accueil >
  • Publications >
  • Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types

Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types

1 avr. 2022Clinical and Translational Medicine

DOI : 10.1002/ctm2.813

Auteurs

Paula Azorin, Florian Bonin, Zakia Tariq, Ambre Petitalot, Florence Coussy, Elisabetta Marangoni, Veronique Becette, Yves Denoux, Anne Vincent‐Salomon, Christophe Le Tourneau, Linda Larbi Cherif, Jerzy Klijanienko, Maud Kamal, Ivan Bièche, Rosette Lidereau, Keltouma Driouch